Log in
Forgot password ?
Become a member for free
Sign up
Sign up
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nasdaq  >  Henry Schein, Inc.    HSIC

News SummaryMost relevantAll newsSector newsTweets 
The feature you requested does not exist. However, we suggest the following feature:

Henry Schein : Completes Acquisition Of A Majority Interest In Dental Cremer

share with twitter share with LinkedIn share with facebook
share via e-mail
01/17/2017 | 02:06pm CET

MELVILLE, N.Y., Jan. 17, 2017 /PRNewswire/ -- Henry Schein, Inc. (Nasdaq: HSIC), the world's largest provider of health care products and services to office-based dental, animal health and medical practitioners, today announced it has completed the acquisition of a majority ownership interest in Dental Cremer S.A., a distributor of dental supplies and equipment in Brazil. The signing of the definitive agreement for this transaction was previously announced on February 5, 2016.

Dental Cremer, previously the dental distribution business of Cremer S.A., had 2016 net sales of approximately $145 million, serves nearly 90,000 dental practitioners across Brazil, and has more than 1,000 team members. Dental Cremer Chief Executive Officer Paulo Batista and members of Dental Cremer's management team will join Henry Schein. Mr. Batista will continue to lead Dental Cremer as Managing Director.

"We are pleased to welcome the Dental Cremer team to Henry Schein," said Stanley M. Bergman, Chairman of the Board and Chief Executive Officer of Henry Schein, Inc. "We first entered the Brazilian dental market in 2014 and our relationship with Dental Cremer underscores our long-term mission to serve dentists throughout Brazil and across South America. Together, we are well-positioned to benefit from market growth that is being fueled by an expanding middle class and aging population. We look forward to combining our resources and identifying new opportunities to help practitioners in Brazil operate successful practices and provide quality care to patients."

Dental Cremer is now part of Henry Schein's Global Dental business, the leading global distributor of products and services, including innovative digital dental technology solutions, to office-based general dental practitioners, dental specialists and dental laboratories.

"We are especially excited to partner with Henry Schein and work together to bring new services and solutions to the Brazilian dental community. We look forward to offering even more customized solutions best suited to our customers' practice needs," said Paulo Batista.

About Henry Schein, Inc.
Henry Schein, Inc. (Nasdaq:HSIC) is the world's largest provider of health care products and services to office-based dental, animal health and medical practitioners. The company also serves dental laboratories, government and institutional health care clinics, and other alternate care sites. A Fortune 500® Company and a member of the S&P 500® and the NASDAQ 100® indexes, Henry Schein employs more than 19,000 Team Schein Members and serves more than 1 million customers.

The company offers a comprehensive selection of products and services, including value-added solutions for operating efficient practices and delivering high-quality care. Henry Schein operates through a centralized and automated distribution network, with a selection of more than 110,000 branded products and Henry Schein private-brand products in stock, as well as more than 150,000 additional products available as special-order items. The company also offers its customers exclusive, innovative technology solutions, including practice management software and e-commerce solutions, as well as a broad range of financial services.

Headquartered in Melville, N.Y., Henry Schein has operations or affiliates in 33 countries. The company's sales reached a record $10.6 billion in 2015, and have grown at a compound annual rate of approximately 15 percent since Henry Schein became a public company in 1995. For more information, visit Henry Schein at www.henryschein.com, Facebook.com/HenrySchein and @HenrySchein on Twitter.

Cautionary Note Regarding Forward-Looking Statements
In accordance with the "Safe Harbor" provisions of the Private Securities Litigation Reform Act of 1995, we provide the following cautionary remarks regarding important factors that, among others, could cause future results to differ materially from the forward-looking statements, expectations and assumptions expressed or implied herein. All forward-looking statements made by us are subject to risks and uncertainties and are not guarantees of future performance. These forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause our actual results, performance and achievements or industry results to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. These statements are identified by the use of such terms as "may," "could," "expect," "intend," "believe," "plan," "estimate," "forecast," "project," "anticipate" or other comparable terms. A full discussion of our operations and financial condition, including factors that may affect our business and future prospects, is contained in documents we have filed with the United States Securities and Exchange Commission, or SEC, and will be contained in all subsequent periodic filings we make with the SEC. These documents identify in detail important risk factors that could cause our actual performance to differ materially from current expectations.

Risk factors and uncertainties that could cause actual results to differ materially from current and historical results include, but are not limited to: effects of a highly competitive and consolidating market; our dependence on third parties for the manufacture and supply of our products; our dependence upon sales personnel, customers, suppliers and manufacturers; our dependence on our senior management; fluctuations in quarterly earnings; risks from expansion of customer purchasing power and multi-tiered costing structures; increases in shipping costs for our products or other service issues with our third-party shippers; general global macro-economic conditions; risks associated with political and economic uncertainty arising from the outcome of the referendum on the membership of the United Kingdom in the European Union; disruptions in financial markets; volatility of the market price of our common stock; changes in the health care industry; implementation of health care laws; failure to comply with regulatory requirements and data privacy laws; risks associated with our global operations; transitional challenges associated with acquisitions and joint ventures, including the failure to achieve anticipated synergies; financial risks associated with acquisitions and joint ventures; litigation risks; the dependence on our continued product development, technical support and successful marketing in the technology segment; increased competition by third party online commerce sites; risks from disruption to our information systems; cyberattacks or other privacy or data security breaches; certain provisions in our governing documents that may discourage third-party acquisitions of us; and changes in tax legislation. The order in which these factors appear should not be construed to indicate their relative importance or priority.

We caution that these factors may not be exhaustive and that many of these factors are beyond our ability to control or predict. Accordingly, any forward-looking statements contained herein should not be relied upon as a prediction of actual results. We undertake no duty and have no obligation to update forward-looking statements.

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/henry-schein-completes-acquisition-of-a-majority-interest-in-dental-cremer-300391527.html

SOURCE Henry Schein, Inc.

share with twitter share with LinkedIn share with facebook
share via e-mail
Latest news on HENRY SCHEIN, INC.
01/17 HENRY SCHEIN : Completes Acquisition Of A Majority Interest In Dental Cremer
01/09 HENRY SCHEIN : Helps Raise $10,000 for AAEP Foundtion to Support Equine Veterina..
01/06 HENRY SCHEIN : Vulcan Custom Dental Becomes a BioHorizons Authorized Milling Cen..
2016 HENRY SCHEIN : Named 'Best Animal Healthcare Product Provider 2016' By Global He..
2016 HENRY SCHEIN : To Present At The 35th Annual J.P. Morgan Healthcare Conference
2016 HENRY SCHEIN : Earns Top Marks In 2017 Corporate Equality Index
2016 HENRY SCHEIN : Completes Investment With Full-Service Dental Distributor Marrode..
2016 HENRY SCHEIN : 18th Annual Holiday Cheer For Children Spreads Joy To Children An..
2016 JAGUAR ANIMAL HEALTH : NetworkNewsBreaks – Jaguar Animal Health (JAGX) Ink..
More news
Sector news : Medical Equipment Wholesale
01/17DJLUXOTTICA FOUNDER : A Lifetime of Deals -- WSJ
01/17DJLUXOTTICA : Merger to Create Eyewear Giant -- WSJ
01/17DJWHAT'S NEWS : Business & Finance -- WSJ
01/16 ESSILOR INTL : Luxottica's merger helps Del Vecchio manage family risks
01/16DJLUXOTTICA : Another Big Splash by Italy's Eyewear King
More sector news : Medical Equipment Wholesale
News from SeekingAlpha
01/09 Mars deal throws a spotlight on the pet care sector
2016 Schein to distribute Jaguar's Neonorm Foal
2016 Tale Of 2 Markets - Cramer's Mad Money (12/1/16)
2016 PATTERSON COMPANIES : Strong Long-Term Trends Intact Despite Brutal Sell Off In ..
2016 Patterson Companies - Buying Opportunity As Shares Have Been Re-Set Amidst Se..
Financials ($)
Sales 2016 11 523 M
EBIT 2016 811 M
Net income 2016 525 M
Debt 2016 885 M
Yield 2016 -
P/E ratio 2016 24,63
P/E ratio 2017 21,64
EV / Sales 2016 1,17x
EV / Sales 2017 1,09x
Capitalization 12 629 M
More Financials
Duration : Period :
Henry Schein, Inc. Technical Analysis Chart | HSIC | US8064071025 | 4-Traders
Full-screen chart
Technical analysis trends HENRY SCHEIN, INC.
Short TermMid-TermLong Term
Technical analysis
Income Statement Evolution
More Financials
Mean consensus OUTPERFORM
Number of Analysts 15
Average target price 172 $
Spread / Average Target 9,5%
Consensus details
EPS Revisions
More Estimates Revisions
Stanley M. Bergman Chairman & Chief Executive Officer
James P. Breslawski President & Director
Steven Paladino Chief Financial Officer, Director & Executive VP
James A. Harding Chief Technology Officer & Senior Vice President
Philip A. Laskawy Lead Independent Director
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
HENRY SCHEIN, INC.3.42%12 696
COLOPLAST A/S1.78%13 978
OWENS & MINOR, INC.2.01%2 228
AMPLIFON SPA1.27%2 222
More Results